Foreign firms: Deception and hope in India's IPR regime
This article was originally published in Scrip
Executive Summary
Intellectual property rights (IPR)-related issues pertaining to the pharmaceutical segment are touchy in India. They figure prominently in the long-running negotiations on the proposed EU-India free trade agreement. Ditto for the US-India tug of war over IPR issues.